During the past decade, Royal Marsden Hospital; Dept of Med-Onc conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 7 clinical trials were completed, i.e. on average, 175% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Marsden Hospital; Dept of Med-Onc" #1 collaborator was "Genentech, Inc." with 2 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "Chugai" with 1 trials as a collaborator, "Exelixis" with 1 trials as a collaborator and "Sarcoma Alliance for Research through Collaboration" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Royal Marsden Hospital; Dept of Med-Onc" are "Breast Cancer" (3 trials), "Gastric Cancer" (2 trials), "Adenocarcinoma" (1 trials), "Bronchial Diseases" (1 trials) and "Carcinoma" (1 trials). Many other conditions were trialed in "Royal Marsden Hospital; Dept of Med-Onc" in a lesser frequency.

Most popular intervention types in "Royal Marsden Hospital; Dept of Med-Onc" are "Drug" (9 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "5-Fluorouracil" (2 trials), "Atezolizumab" (2 trials) and "Bevacizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Marsden Hospital; Dept of Med-Onc" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Royal Marsden Hospital; Dept of Med-Onc". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Royal Marsden Hospital; Dept of Med-Onc, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Marsden Hospital; Dept of Med-Onc, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".